Blogs
April 30, 2026 by Gina Breckenridge
As RFID adoption surpasses 34% in U.S. hospital pharmacies, the conversation is shifting. It’s no longer just about implementing new technology—it’s about whether that technology can integrate, communicate, and scale across the broader healthcare ecosystem. Healthcare leaders are asking a critical question: Can my system speak the same language as the rest of the healthcare supply chain? The answer lies in interoperability and adherence to global standards, such as those established by GS1.
Healthcare systems today are under immense pressure to do more with less. Yet many hospitals and pharmacies are still operating within fragmented systems that don’t communicate effectively with one another. These silos introduce inefficiencies, increase the risk of errors, and limit end-to-end visibility and control across the medication lifecycle. Interoperability changes that.By enabling systems to exchange and interpret trusted data seamlessly, interoperability creates a connected infrastructure where medication inventory can be tracked, verified, and managed with confidence.
GS1 standards provide a common framework for identifying, capturing, and sharing product information across the global supply chain. In healthcare, GS1-compliant RFID enables a new level of visibility and control over medication inventory. Items can be uniquely identified and tracked in real time, helping reduce the risk of counterfeit or compromised medications reaching patient care areas. These standards align with requirements set forth by agencies such as the Drug Supply Chain Security Act (DSCSA). The Food and Drug Administration (FDA) implemented rigorous DSCSA requirements in October 2024, focusing on improving electronic systems to accurately trace medications as they move throughout the supply chain. By adopting GS1 standards—rather than limiting RFID to a single vendor’s technology or tags—health systems, pharmacies, distributors, and manufacturers can share a single source of truth for medication inventory identification, tracking, and verification, allowing for end-to-end traceability and full supply chain transparency.
Closed, proprietary medication management systems are no longer sustainable. These systems that rely on vendor-specific RFID tags or technology limit interoperability and increase the risk of long-term vendor lock-in. Technology should simplify healthcare operations, not introduce new barriers. That’s why more healthcare organizations are prioritizing interoperable medication inventory management systems. By leveraging GS1-compliant RFID, systems can read any compliant tag—regardless of vendor—creating a shared source of truth for critical medication data. The result is reduced fragmentation, stronger collaboration across stakeholders, and technology investments that remain viable as the ecosystem evolves.
Pharmaceutical manufacturers like Fresenius Kabi are increasingly embedding RFID tags directly into medication packaging at the point of production, in line with GS1 standards. This enables seamless interoperability from the moment a medication enters the supply chain. For providers, this means faster workflows, time savings, and greater confidence in the accuracy of medication inventory data. And for the healthcare industry as a whole, it represents a critical step toward a fully connected, end-to-end medication management ecosystem.
As the healthcare industry continues to evolve, the ability to share accurate, real-time data across systems will be essential. That’s why Intelliguard is committed to transforming healthcare by advancing open interoperability and the adoption of GS1 standards to support a transparent, resilient medication inventory and pharmaceutical supply chain. Health systems and trading partners that embrace open standards today are not just solving current challenges; they are building a future-proof infrastructure that creates a smarter, more connected healthcare system and supply chain for patients and providers.